Early Metabolic Resuscitation for Septic Shock

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-04

Study Completion Date

2020-05-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This phase II trial studies how well early metabolic resuscitation therapy works in reducing multi-organ dysfunction in patients with septic shock. Early metabolic resuscitation is made of large doses of glucose, protein, and essential metabolic molecules that may help lower the effects of septic shock on the body. Giving patients early metabolic resuscitation in combination with standard of care may work better in reducing multi-organ dysfunction syndrome in patients with septic shock compared to standard of care alone.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis

NCT02885688

Septic Shock

WITHDRAWN PHASE2

Preemptive Resuscitation for Eradication of Septic Shock

NCT01449721

Sepsis Severe Sepsis

COMPLETED NA

Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study

NCT04288635

Septic Shock Multiple Organ Failure

RECRUITING

A Randomized Controlled Study of Enteral Nutrition in Septic Shock

NCT02025127

Septic Shock

COMPLETED NA

Protocol-driven Hemodynamic Support for Patients With Septic Shock

NCT00335907

Shock, Septic Severe Sepsis Sepsis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To assess the efficacy of administering early metabolic resuscitation with standard of care (SC + EMR) in patients diagnosed with septic shock for reducing 28-day mortality versus using the standard of care alone (SC).

SECONDARY OBJECTIVES:

I. To assess whether early metabolic resuscitation with standard of care (SC + EMR) is an effective strategy to reduce intensive care unit (ICU) mortality, hospital mortality, and 90-day mortality of septic shock patients relative to SC.

II. To compare the time to death from any cause between patients administered SC + EMR versus SC after being diagnosed with septic shock.

III. To assess whether SC + EMR is an effective strategy to reduce complications of septic shock such as: i) acute kidney injury, ii) dialysis requirements, iii) need for cardiovascular support or days on vasopressors, iv) need for invasive ventilation, days on ventilator support, v) duration of ICU stay, and vi) duration of hospital stay versus SC.

IV. To describe the presence of any adverse effects between the two study groups (SC + EMR group versus \[vs\] SC group); thus, characterizing their safety.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP I: Patients receive standard of care for septic shock.

GROUP II: Patients receive standard of care treatment for septic shock and early metabolic resuscitation (IV) over continuous infusion for up to 7 days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Organ Failure Septic Shock Severe Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I (standard of care)

Patients receive standard of care for septic shock.

Group Type ACTIVE_COMPARATOR

Best Practice

Intervention Type OTHER

Receive standard of care

Group II (early metabolic resuscitation)

Patients receive standard of care treatment for septic shock and early metabolic resuscitation (IV) over continuous infusion for up to 7 days.

Group Type EXPERIMENTAL

Best Practice

Intervention Type OTHER

Receive standard of care

early metabolic resuscitation

Intervention Type DIETARY_SUPPLEMENT

Given Intravenous

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Best Practice

Receive standard of care

Intervention Type OTHER

early metabolic resuscitation

Given Intravenous

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

standard of care standard therapy hyperalimentation EMR glucose protein essential metabolic molecules

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to the adult medical intensive care unit (MICU).
* Diagnosis of septic shock within 12 hours of ICU admission defined as meeting criteria for sepsis in addition to the following: A) Vasopressor therapy needed to elevate mean arterial pressure (MAP) \>= 65 mmg Hg. B) Lactate \> 2 mmol/L (18 mg/dL) after adequate fluid resuscitation.
* Sequential Organ Failure Assessment (SOFA) score meeting the following requirements A) Cardiovascular SOFA \>= 2 B) Total SOFA score =\< 12.
* Patients meeting the above and not able to tolerate enteral nutrition above 70% of their estimated daily caloric need.

* Hyperphosphatemia: Serum phosphorous \> 5.5 mg/dL.
* Patient with a history of metabolic abnormality in any one of the following amino acids: alanine, arginine, cysteine hydrochloride, glycine, histidine, isoleucine, leucine, lysine acetate, methionine, phenylalanine, phosphoric acid, proline, serine, threonine, tryptophan, and valine.

Exclusion Criteria

* Do not resuscitate (DNR).
* Comfort care and end-of-life patients.
* Patients with SOFA scores greater than 12.
* Pregnant women.
* Jehovah Witnesses that do not accept albumin.
* Active bleeding (e.g., gastrointestinal bleeding).
* Acute neurological syndromes (e.g., stroke, hemorrhage, etc.).
* End-stage renal disease (ESRD).
* Chronic liver disease

* Child-Pugh class C
* Diagnosis of cirrhosis
* Heart rate less than 50 beats per minute (bpm).
* Respiratory rate less than 8 respirations per minute (rpm).
* Temperature less than 95 degrees Fahrenheit (F) or 35 degrees Celsius (C).
* Tumor lysis syndrome.
* Sulfite allergy: amino acids administration are contraindicated. It is more common in steroid dependent asthmatics. (Please note that this is NOT sulfa allergy and is NOT contraindicated patients with sulfa allergy). Sulfites are present in dried fruits, beer, wines, sausages, jams, maple syrup, and many other food products.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No